N/A
N=444
Brief Online Interventions for Alcohol Use
Alcohol Use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT03438539 ↗Enrolled (actual)
444
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Alcohol Use — 19.4; 16.3; 15.3; 19.1 percentage heavy drinking days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Normative Feedback (Behavioral); Inhibitory Control Training (Behavioral); Working Memory Training (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Craig Rush
- Primary completion
- Jul 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Alcohol Use |
19.4; 16.3; 15.3; 19.1; 19.6; 21.0 | — |
| SECONDARY Percentage of Sessions Completed (Feasibility) |
68.6; 63.3; 56.5; 66.1; 74.7; 59.9 | — |
| SECONDARY Treatment Acceptability Questionnaire |
80.8; 75.9; 77.9; 84.2; 81.9; 74.6 | — |
Summary
The purpose of this study is to test the feasibility and acceptability of delivering cognitive training over mTurk. Subjects will be randomized to a 1) inhibitory control training condition, 2) working memory training condition, or 3) control training condition. Recent studies have also demonstrated the feasibility and potential efficacy of delivering brief normative feedback to reduce alcohol consumption through mTurk. In these brief interventions, subjects are provided information about their drinking compared to their same age and gendered peers. Approximately half of the subjects in each cognitive training group will receive normative feedback to evaluate effects on alcohol consumption and possible interactions with cognitive training. This study will focus on alcohol use given the ease and clinical acceptance of alcohol use self-report as a primary outcome.
Eligibility Criteria
Inclusion Criteria
- Self-reported past week alcohol use.
- Meet criteria for Alcohol Use Disorder (AUD), verified by computerized questionnaire for DSM-V AUD criteria (Appendix A).
- Age 21 years or older.
- Express interest in completing a 2-week study involving daily cognitive tasks.
- Residence in the United States
Exclusion Criteria
- N/A
Data sourced from ClinicalTrials.gov (NCT03438539). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.